SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-023257
Filing Date
2022-02-14
Accepted
2022-02-14 17:28:42
Documents
12
Period of Report
2022-02-11
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm226738d1_8k.htm   iXBRL 8-K 23099
  Complete submission text file 0001104659-22-023257.txt   195949

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA jagx-20220211.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20220211_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20220211_pre.xml EX-101.PRE 22615
6 EXTRACTED XBRL INSTANCE DOCUMENT tm226738d1_8k_htm.xml XML 3604
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 22635201
SIC: 2834 Pharmaceutical Preparations